Tenosynovial Giant Cell Tumor
Oncology·MeSH: Giant Cell Tumor of Tendon Sheath
Prevalence
30.0 / 100K
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Approved(1)
Frequently asked questions
How many drugs are in development for Tenosynovial Giant Cell Tumor?
BioSniper tracks 1 drug in development for Tenosynovial Giant Cell Tumor across 1 company.
How many clinical trials target Tenosynovial Giant Cell Tumor?
There are 5 clinical trials targeting Tenosynovial Giant Cell Tumor tracked by BioSniper.
What is the prevalence of Tenosynovial Giant Cell Tumor?
The estimated prevalence of Tenosynovial Giant Cell Tumor is approximately 30.0 per 100,000 population.
Deep-dive into Tenosynovial Giant Cell Tumor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis